BioRestorative Therapies Future Growth
Future criteria checks 2/6
BioRestorative Therapies is forecast to grow earnings and revenue by 50.2% and 74.2% per annum respectively while EPS is expected to grow by 53.1% per annum.
Key information
50.2%
Earnings growth rate
53.1%
EPS growth rate
Biotechs earnings growth | 24.0% |
Revenue growth rate | 74.2% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 30 Apr 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 0 | -25 | N/A | N/A | 2 |
12/31/2025 | 0 | -21 | N/A | N/A | 2 |
12/31/2024 | 0 | -18 | N/A | N/A | 2 |
12/31/2023 | 0 | -14 | -7 | -6 | N/A |
9/30/2023 | 0 | -16 | -7 | -6 | N/A |
6/30/2023 | 0 | -18 | -7 | -7 | N/A |
3/31/2023 | 0 | -19 | -7 | -7 | N/A |
12/31/2022 | 0 | -18 | -6 | -6 | N/A |
9/30/2022 | 0 | -35 | -6 | -5 | N/A |
6/30/2022 | 0 | -34 | -5 | -5 | N/A |
3/31/2022 | 0 | -33 | -4 | -4 | N/A |
12/31/2021 | 0 | -44 | -3 | -3 | N/A |
9/30/2021 | 0 | -30 | -3 | -3 | N/A |
6/30/2021 | 0 | -26 | -3 | -3 | N/A |
3/31/2021 | 0 | -19 | -2 | -2 | N/A |
12/31/2020 | 0 | -11 | -2 | -2 | N/A |
9/30/2020 | 0 | -7 | -3 | -3 | N/A |
6/30/2020 | 0 | -11 | -4 | -4 | N/A |
3/31/2020 | 0 | -18 | -5 | -5 | N/A |
12/31/2019 | 0 | -15 | -7 | -7 | N/A |
9/30/2019 | 0 | -17 | -7 | -7 | N/A |
6/30/2019 | 0 | -15 | -6 | -6 | N/A |
3/31/2019 | 0 | -14 | -6 | -6 | N/A |
12/31/2018 | 0 | -13 | -5 | -5 | N/A |
9/30/2018 | 0 | -11 | -5 | -5 | N/A |
6/30/2018 | 0 | -10 | -4 | -4 | N/A |
3/31/2018 | 0 | -9 | -4 | -4 | N/A |
12/31/2017 | 0 | -9 | -4 | -4 | N/A |
9/30/2017 | 0 | -10 | N/A | -4 | N/A |
6/30/2017 | 0 | -9 | N/A | -4 | N/A |
3/31/2017 | 0 | -9 | N/A | -5 | N/A |
12/31/2016 | 0 | -9 | N/A | -5 | N/A |
9/30/2016 | 0 | -10 | N/A | -5 | N/A |
6/30/2016 | 0 | -9 | N/A | -4 | N/A |
3/31/2016 | 0 | -9 | N/A | -4 | N/A |
12/31/2015 | 1 | -8 | N/A | -3 | N/A |
9/30/2015 | 1 | -6 | N/A | -3 | N/A |
6/30/2015 | 1 | -6 | N/A | -3 | N/A |
3/31/2015 | 1 | -6 | N/A | -3 | N/A |
12/31/2014 | 0 | -6 | N/A | -3 | N/A |
9/30/2014 | 0 | -6 | N/A | -3 | N/A |
6/30/2014 | 0 | -6 | N/A | -3 | N/A |
3/31/2014 | 0 | -6 | N/A | -3 | N/A |
12/31/2013 | 0 | -6 | N/A | -3 | N/A |
9/30/2013 | 0 | -6 | N/A | -3 | N/A |
6/30/2013 | 0 | -6 | N/A | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BRTX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: BRTX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: BRTX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: BRTX's revenue (74.2% per year) is forecast to grow faster than the US market (8.3% per year).
High Growth Revenue: BRTX's revenue (74.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BRTX's Return on Equity is forecast to be high in 3 years time